Año 2025 / Volumen 117 / Número 7
Original
Visceral adiposity index as a key predictor of severity in acute pancreatitis - A large-scale retrospective cohort study

374-381

DOI: 10.17235/reed.2025.10864/2024

Tingting Wang, Fei Cao, Jiajun He, Lei Zhu, Xiaoxi Yang, Shuli Ma, Quping Zhu, Yuanhao Li, Chuting Yang, Jun Liu, Chaowu Chen, Chen Weiwei,

Resumen
Background and aims: visceral adipose tissue has been closely connected with the severity of acute pancreatitis (AP). Visceral adiposity index (VAI) is a mathematical model that consists of waist circumference, body mass index, triglyceride and high-density lipoprotein cholesterol, which has been demonstrated to be a better indicator of visceral fat than other traditional indices. This study aimed to evaluate the relationship between VAI and the severity of AP. Methods: a retrospective analysis was conducted on a cohort of 1,174 patients diagnosed with AP. These patients were categorized into two groups based on their VAI values: normal VAI (NVAI) group and elevated VAI (EVAI) group. Results: the EVAI group patients were much younger, mainly male, and had a higher incidence of severe acute pancreatitis (SAP) compared with the NVAI group (p < 0.001). The EVAI group had a higher incidence of persistent respiratory failure, acute peripancreatic fluid collection (APFC) and acute necrotic collection (ANC). The VAI level and the percentage of EVAI showed an increasing trend with the severity of AP (p < 0.001). EVAI was the most independent risk factor for persistent respiratory failure (OR = 6.405, 95 % CI: 2.317-17.705), APFC (OR = 2.093, 95 % CI: 1.255-3.578) and ANC (OR = 4.910, 95 % CI: 1.736-13.887). Conclusions: EVAI was strongly related to the severity of AP. It was the most independent risk factor of persistent respiratory failure, APFC and ANC.
Resumen coloquial
Acute pancreatitis (AP) is a complex inflammatory disorder of the pancreas that is associated with substantial morbidity and mortality. Recent studies have indicated that visceral adipose tissue (VAT) is closely connected with the severity of AP. Visceral adiposity index (VAI) is a mathematical model that consists of body mass index, waist circumference, triglyceride and high-density lipoprotein cholesterol, which has been demonstrated to be a better indicator of visceral fat than other traditional indices. Our study demonstrated that elevated VAI was strongly related to the severity of AP.
Nuevo comentario
Comentarios
No hay comentarios para este artículo.
Bibliografía
1. Lee PJ, Papachristou GI. New insights into acute pancreatitis. Nat Rev Gastroenterol Hepatol. 2019;16(8):479-496. eng. doi:10.1038/s41575-019-0158-2.
2. Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013 Jan;62(1):102-11. eng. Epub 2012/10/27. doi:10.1136/gutjnl-2012-302779.
3. Hou S, Tang X, Cui H, et al. Fatty liver disease is associated with the severity of acute pancreatitis:A systematic review and meta-analysis. Int J Surg. 2019 May;65:147-153. eng. Epub 2019/04/16. doi:10.1016/j.ijsu.2019.04.003.
4. Biczo G, Vegh ET, Shalbueva N, et al. Mitochondrial Dysfunction, Through Impaired Autophagy, Leads to Endoplasmic Reticulum Stress, Deregulated Lipid Metabolism, and Pancreatitis in Animal Models. Gastroenterology. 2018;154(3):689-703. eng. doi:10.1053/j.gastro.2017.10.012.
5. Li X, Guo X, Ji H, et al. Relationships between Metabolic Comorbidities and Occurrence, Severity, and Outcomes in Patients with Acute Pancreatitis: A Narrative Review. Biomed Res Int. 2019;2019:2645926. Epub 2019/11/07. doi:10.1155/2019/2645926.
6. Chen SM, Xiong GS, Wu SM. Is obesity an indicator of complications and mortality in acute pancreatitis? An updated meta-analysis. J Dig Dis. 2012 May;13(5):244-51. Epub 2012/04/17. doi:10.1111/j.1751-2980.2012.00587.x.
7. Wang X, Rao H, Liu F, et al. Recent Advances in Adipose Tissue Dysfunction and Its Role in the Pathogenesis of Non-Alcoholic Fatty Liver Disease. Cells. 2021;10(12). eng. doi:10.3390/cells10123300.
8. González-García I, Freire-Agulleiro Ó, Nakaya N, et al. Olfactomedin 2 deficiency protects against diet-induced obesity. Metabolism. 2022:155122. eng. doi:10.1016/j.metabol.2021.155122.
9. Juchnicka I, Kuzmicki M, Szamatowicz J. Ceramides and Sphingosino-1-Phosphate in Obesity. Front Endocrinol (Lausanne). 2021;12:635995. Epub 2021/06/01. doi:10.3389/fendo.2021.635995.
10. de Oliveira C, Khatua B, Noel P, et al. Pancreatic triglyceride lipase mediates lipotoxic systemic inflammation. J Clin Invest. 2020 Apr 1;130(4):1931-1947. eng. Epub 2020/01/10. doi:10.1172/jci132767.
11. Natu A, Stevens T, Kang L, et al. Visceral Adiposity Predicts Severity of Acute Pancreatitis. Pancreas. 2017 Jul;46(6):776-781. Epub 2017/06/14. doi:10.1097/MPA.0000000000000845.
12. Xie J, Xu L, Pan Y, et al. Impact of visceral adiposity on severity of acute pancreatitis: a propensity score-matched analysis. BMC Gastroenterol. 2019 Jun 13;19(1):87. Epub 2019/06/15. doi:10.1186/s12876-019-1015-z.
13. Ismaiel A, Jaaouani A, Leucuta DC, et al. The Visceral Adiposity Index in Non-Alcoholic Fatty Liver Disease and Liver Fibrosis-Systematic Review and Meta-Analysis. Biomedicines. 2021 Dec 13;9(12). eng. Epub 2021/12/25. doi:10.3390/biomedicines9121890.
14. Ravani JPR, Sbaffi BC, Monteiro AC, et al. The Visceral Adiposity Index Is a Better Predictor of Excess Visceral Fat in Military Pilots: A Cross-sectional Observational Study. Mil Med. 2023 Jul 22;188(7-8):e2003-e2009. eng. Epub 2022/10/22. doi:10.1093/milmed/usac319.
15. Xia W, Yu H, Huang Y, et al. The visceral adiposity index predicts the severity of hyperlipidaemic acute pancreatitis. Intern Emerg Med. 2021 Aug 2. Epub 2021/08/04. doi:10.1007/s11739-021-02819-4.
16. association Cim. Integrated Traditional Chinese and Western Medicine Practice Guidelines for Diagnosis and Treatment of Acute Pancreatitis. 2020. Available from: https://www.kdocs.cn/l/cp2YmJnGzOQU.
17. Berglund L, Brunzell JD, Goldberg AC, et al. Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012 Sep;97(9):2969-89. eng. Epub 2012/09/11. doi:10.1210/jc.2011-3213.
18. de Pretis N, Amodio A, Frulloni L. Hypertriglyceridemic pancreatitis: Epidemiology, pathophysiology and clinical management. United European Gastroenterol J. 2018 Jun;6(5):649-655. eng. Epub 2018/08/08. doi:10.1177/2050640618755002.
19. Zhang R, Deng L, Jin T, et al. Hypertriglyceridaemia-associated acute pancreatitis: diagnosis and impact on severity. HPB (Oxford). 2019 Sep;21(9):1240-1249. eng. Epub 2019/03/20. doi:10.1016/j.hpb.2019.01.015.
20. Wu BU, Batech M, Quezada M, et al. Dynamic Measurement of Disease Activity in Acute Pancreatitis: The Pancreatitis Activity Scoring System. Am J Gastroenterol. 2017;112(7):1144-1152. eng. doi:10.1038/ajg.2017.114.
21. Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1):102-111. eng. doi:10.1136/gutjnl-2012-302779.
22. Wan H, Wang Y, Xiang Q, et al. Associations between abdominal obesity indices and diabetic complications: Chinese visceral adiposity index and neck circumference. Cardiovasc Diabetol. 2020;19(1):118. eng. doi:10.1186/s12933-020-01095-4.
23. Zimmet P, M M Alberti KG, Serrano Ríos M. [A new international diabetes federation worldwide definition of the metabolic syndrome: the rationale and the results]. Rev Esp Cardiol. 2005;58(12):1371-1376. spa.
24. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157-163. eng.
25. Amato MC, Giordano C, Galia M, et al. Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010 Apr;33(4):920-2. Epub 2010/01/14. doi:10.2337/dc09-1825.
26. Wei J, Liu X, Xue H, et al. Comparisons of Visceral Adiposity Index, Body Shape Index, Body Mass Index and Waist Circumference and Their Associations with Diabetes Mellitus in Adults. Nutrients. 2019;11(7). eng. doi:10.3390/nu11071580.
27. Amato MC, Giordano C. Visceral adiposity index: an indicator of adipose tissue dysfunction. Int J Endocrinol. 2014;2014:730827. Epub 2014/05/16. doi:10.1155/2014/730827.
28. Zhou C, Zhang Z, Liu M, et al. Association of visceral adiposity index with new-onset type 2 diabetes and impaired fasting glucose in hypertensive Chinese adults. Eat Weight Disord. 2021. eng. doi:10.1007/s40519-021-01187-4.
29. He S, Yang J, Li X, et al. Visceral adiposity index is associated with lung function impairment: a population-based study. Respir Res. 2021;22(1):2. eng. doi:10.1186/s12931-020-01599-3.
30. Xu C, Ma Z, Wang Y, et al. Visceral adiposity index as a predictor of NAFLD: A prospective study with 4-year follow-up. Liver Int. 2018;38(12):2294-2300. eng. doi:10.1111/liv.13941.
31. Wen J, Yuan H. Independent association between the visceral adiposity index and microalbuminuria in patients with newly diagnosed type 2 diabetes. Diabetes Metab Res Rev. 2020;36(1):e3198. eng. doi:10.1002/dmrr.3198.
32. Wang Y, Li Z, Li F. Nonlinear relationship between visceral adiposity index and lung function: a population-based study. Respir Res. 2021 May 24;22(1):161. Epub 2021/05/26. doi:10.1186/s12931-021-01751-7.
33. Nam KW, Kwon HM, Jeong HY, et al. Visceral adiposity index is associated with silent brain infarct in a healthy population. Sci Rep. 2020 Oct 14;10(1):17271. Epub 2020/10/16. doi:10.1038/s41598-020-74454-6.
34. Okamura T, Hashimoto Y, Hamaguchi M, et al. The visceral adiposity index is a predictor of incident nonalcoholic fatty liver disease: A population-based longitudinal study. Clin Res Hepatol Gastroenterol. 2020 Jun;44(3):375-383. eng. Epub 2020/05/22. doi:10.1016/j.clinre.2019.04.002.
35. Khatua B, El-Kurdi B, Singh VP. Obesity and pancreatitis. Curr Opin Gastroenterol. 2017 Sep;33(5):374-382. eng. Epub 2017/07/19. doi:10.1097/mog.0000000000000386.
Artículos relacionados

Editorial

Etiological diagnosis of recurrent acute pancreatitis

DOI: 10.17235/reed.2024.10404/2024

Carta

Anemia can predict organ failure in acute pancreatitis

DOI: 10.17235/reed.2023.9700/2023

Editorial

Acute pancreatitis: an opportunity for gastroenterology hospitalists?

DOI: 10.17235/reed.2022.8573/2022

Imagen en Patología Digestiva

Endoscopic necrosectomy – when the gastroenterologist faces his greatest nightmare.

DOI: 10.17235/reed.2021.8403/2021

Imagen en Patología Digestiva

Wunderlich syndrome secondary to severe acute pancreatitis

DOI: 10.17235/reed.2021.8184/2021

Carta

Daño pancreático: pancreatitis aguda en pacientes COVID-19

DOI: 10.17235/reed.2021.7807/2021

Carta

Pancreatic injury in COVID-19: pathogenesis and challenges

DOI: 10.17235/reed.2020.7541/2020

Carta

SARS-CoV-2 and acute pancreatitis: a new etiological agent?

DOI: 10.17235/reed.2020.7481/2020

Carta

Acute pancreatitis associated with levofloxacin

DOI: 10.17235/reed.2020.6652/2019

Imagen en Patología Digestiva

Endoscopic therapy in disconnected duct syndrome: re-connecting the duct

DOI: 10.17235/reed.2020.6650/2019

Imagen en Patología Digestiva

Perforación de colon por fistulización de pseudoquiste pancreático

DOI: 10.17235/reed.2018.5884/2018

Imagen en Patología Digestiva

A rare case of acute obstructive suppurative pancreatic ductitis associated with ERCP

DOI: 10.17235/reed.2018.5756/2018

Carta al Editor

A patient with Castleman’s disease mimicking acute pancreatitis

DOI: 10.17235/reed.2017.5120/2017

Carta al Editor

Genetics in idiopathic pancreatitis and acute recurrent pancreatitis

DOI: 10.17235/reed.2017.4632/2016

Original

Estudio multicéntrico de seguridad en endoscopia bariátrica

DOI: 10.17235/reed.2017.4499/2016

Carta al Editor

Hematoma gástrico intramural en el contexto de una pancreatitis aguda

DOI: 10.17235/reed.2017.4494/2016

Caso Clínico

Pancreatitits aguda necroticohemorrágica en malaria falciparum

DOI: 10.17235/reed.2015.3768/2015

Instrucciones para citar
Wang T, Cao F, He J, Zhu L, Yang X, Ma S, et all. Visceral adiposity index as a key predictor of severity in acute pancreatitis - A large-scale retrospective cohort study. 10864/2024


Descargar en un gestor de citas

Descargue la cita de este artículo haciendo clic en uno de los siguientes gestores de citas:

Métrica
Este artículo ha sido visitado 64 veces.
Este artículo ha sido descargado 1 veces.

Estadísticas de Dimensions


Estadísticas de Plum Analytics

Ficha Técnica

Recibido: 12/10/2024

Aceptado: 06/02/2025

Prepublicado: 19/02/2025

Publicado: 08/07/2025

Tiempo de revisión del artículo: 112 días

Tiempo de prepublicación: 130 días

Tiempo de edición del artículo: 269 días


Compartir
Este artículo aun no tiene valoraciones.
Valoración del lector:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
La REED es el órgano oficial de la Sociedad Española de Patología Digestiva, la SociedadEspañola de Endoscopia Digestiva y la Asociación Española de Ecografía Digestiva
Política de cookies Política de Privacidad Aviso Legal © Copyright 2025 y Creative Commons. Revista Española de Enfermedades Digestivas